浸润性乳腺癌超声特征与乳腺癌特异性生存期的关联
在单乳腺服务中心前瞻性收集2010年4月至2012年4月319例连续女性(平均年龄63岁)的335个超声可见浸润性乳腺癌,由对结局不知情的放射科医生按BI-RADS词典回顾性评估超声特征。中位随访80.9个月,发生30例乳腺癌死亡和45例非乳腺癌死亡。远端回声增强、局灶性水肿和皮肤受累与乳腺癌死亡强相关,多变量分析中保持预后意义。
要点
- 远端回声增强者5年乳腺癌特异性生存率为76%,低于远端声影者的88%、无远端效应者的96%和混合效应者的100%(p<0.0002)。
- 超声皮肤受累者5年乳腺癌特异性生存率为73%,无皮肤受累者为92%(p<0.0001)。
- 局灶性水肿者5年乳腺癌特异性生存率为56%,无局灶性水肿者为89%(p=0.0002)。
核心结论
- 远端回声增强、局灶性水肿和皮肤受累与乳腺癌死亡强相关。
- 考虑乳腺癌管理时,可将这些因素与病灶大小及其他常用术前预后特征一并纳入考量。
研究设计与样本
- 前瞻性数据收集(2010年4月至2012年4月)于单乳腺服务中心,纳入319例连续女性(平均年龄63岁)的335个超声可见浸润性乳腺癌。
- 超声特征由对结局不知情的放射科医生根据记录图像按BI-RADS词典回顾性评估。
- 生存和死因从本地和国家来源确定,采用Kaplan-Meier生存曲线和log-rank检验进行统计分析。
关键影像表现/征象
- 远端回声增强、远端声影、无远端效应和混合效应分别对应5年乳腺癌特异性生存率76%、88%、96%和100%(p<0.0002)。
- 超声皮肤受累者5年乳腺癌特异性生存率为73%,无皮肤受累者为92%(p<0.0001)。
- 局灶性水肿者5年乳腺癌特异性生存率为56%,无局灶性水肿者为89%(p=0.0002)。
- 超声肿瘤大小与乳腺癌特异性生存率存在显著关联(p<0.0001)。
诊断标准与关键数值
- 超声特征按BI-RADS词典评估。
- 远端回声增强者5年乳腺癌特异性生存率76%,远端声影者88%,无远端效应者96%,混合效应者100%(p<0.0002)。
- 皮肤受累者5年乳腺癌特异性生存率73%,无皮肤受累者92%(p<0.0001)。
- 局灶性水肿者5年乳腺癌特异性生存率56%,无局灶性水肿者89%(p=0.0002)。
临床应用与阅片要点
- 阅片和报告乳腺超声时,需关注并描述远端回声增强、局灶性水肿和皮肤受累等特征。
- 这些超声特征与乳腺癌特异性生存期相关,可结合病灶大小及其他常用术前预后特征综合考量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To assess whether ultrasound features of breast cancer are associated with breast cancer specific survival (BCSS).
MATERIALS AND METHODS: Within a single breast service, data was collected prospectively (April 2010-April 2012) from 319 consecutive women (mean age 63 years) with 335 ultrasound-visible invasive breast cancers. Ultrasound features were evaluated retrospectively from the recorded images according to the Breast Imaging Reporting and Data System (BI-RADS) lexicon by a radiologist blinded to outcomes. Survival and cause of death were ascertained from local and national sources. Kaplan-Meier survival curves were generated, and statistical significance tested using the log-rank test.
RESULTS: Mean follow-up in those alive was 80.9 months. Thirty breast cancer deaths and 45 non-breast cancer deaths occurred. Five-year BCSS in the presence of distal acoustic enhancement was 76% compared to 88%, 96%, and 100% for those with distal shadowing, no distal effect or combined effect respectively (p<0.0002). Patients with sonographic skin involvement had 73% 5-year BCSS compared to 92% for no skin involvement (p<0.0001). Focal oedema was associated with 56% 5-year BCSS compared to 89% for those without (p=0.0002). A significant association was demonstrated between ultrasound tumour size and BCSS (p<0.0001). At multivariate analysis, skin changes, distal enhancement, and focal oedema maintained prognostic significance.
CONCLUSION: Distal enhancement, focal oedema, and skin involvement have strong associations with breast cancer death. These factors could be taken into account, along with lesion size and other commonly used preoperative prognostic features, when considering management of women with breast cancer.
引用
- Lawson BT, Vinnicombe S, Whelehan P, et al. Associations between the ultrasound features of invasive breast cancer and breast cancer specific survival. Clin Radiol. 2020. PMID: 32807378. doi:10.1016/j.crad.2020.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。